Skip to main content
. 2011 Nov 5;6:150. doi: 10.1186/1748-717X-6-150

Figure 3.

Figure 3

Four-year biochemical relapse-free survival in patients with preoperative prostate-specific antigen (PSA) ≥ 10 ng/ml and that in patients with preoperative PSA < 10 ng/ml.